ADHD

Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\ADHD.php on line 2
ADHD

LE WE PMID CA

ADHD

Addiction (BASKET)

ADHD

Atomoxetine

Attention (Neurophysiology)

Autism

Decision (Neurophysiology)

Endophenotype

Fetal alcohol syndrome

Guanfacin

Lisdexamfetamine

Modafinil

Prefrontal cortex

1999 1	Attention deficit hyperactivity disorder--a review. [10621994] Br J Gen Pract 49(444): 563-71 (1999)
2008 2	Attention deficit hyperactivity disorder in adulthood: diagnosis, etiology and therapy. [19629241] Dtsch Arztebl Int 105(17): 311-7 (2008)
2004 3	Diagnostic controversies in adult attention deficit hyperactivity disorder. [15514392] Am J Psychiatry 161(11): 1948-56 (2004)
2003 4	Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. [14594733] Am J Psychiatry 160(11): 1909-18 (2003)
2009 5	The restless brain: attention-deficit hyperactivity disorder, resting-state functional connectivity, and intrasubject variability. [19835673] Can J Psychiatry 54(10): 665-72 (2009)
2009 6	Neuroimaging in attention-deficit hyperactivity disorder: beyond the frontostriatal circuitry. [19835672] Can J Psychiatry 54(10): 651-64 (2009)
2009 7	Comorbidity and neuroimaging in attention-deficit hyperactivity disorder. [19835671] Can J Psychiatry 54(10): 649-50 (2009)
2001 8	The Diagnosis and Management of Attention-Deficit/Hyperactivity Disorder in Pediatric Patients. [15014618] Prim Care Companion J Clin Psychiatry 3(2): 66-77 (2001)
2008 9	Acute atomoxetine treatment of younger and older children with ADHD: a meta-analysis of tolerability and efficacy. [18793405] Child Adolesc Psychiatry Ment Health 2(1): 25 (2008)
2009 10	Developmental psychopathology: Attention Deficit Hyperactivity Disorder (ADHD). [19761584] BMC Psychiatry 9(): 58 (2009)
2009 11	A review of long-acting medications for ADHD in Canada. [19881943] J Can Acad Child Adolesc Psychiatry 18(4): 331-9 (2009)
2009 12	A clinical overview of sleep and attention-deficit/hyperactivity disorder in children and adolescents. [19495429] J Can Acad Child Adolesc Psychiatry 18(2): 92-102 (2009)
2009 13	Management of attention-deficit hyperactivity disorder in adults: focus on methylphenidate hydrochloride. [19721722] Neuropsychiatr Dis Treat 5(): 421-32 (2009)
2009 14	Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a review. [19557116] Neuropsychiatr Dis Treat 5(): 215-26 (2009)
2008 15	Treatment of adults with attention-deficit/hyperactivity disorder. [18728745] Neuropsychiatr Dis Treat 4(2): 389-403 (2008)
2008 16	Treatment of adults with attention-deficit/hyperactivity disorder. [18728812] Neuropsychiatr Dis Treat 4(1): 107-21 (2008)
2007 17	A review of modafinil film-coated tablets for attention-deficit/hyperactivity disorder in children and adolescents. [19300563] Neuropsychiatr Dis Treat 3(3): 293-301 (2007)
2004 18	Involvement of norepinephrine in the control of activity and attentive processes in animal models of attention deficit hyperactivity disorder. [15303310] Neural Plast 11(1-2): 133-49 (2004)
2004 19	Dysfunctions in dopamine systems and ADHD: evidence from animals and modeling. [15303308] Neural Plast 11(1-2): 97-114 (2004)
2004 20	Experimental investigations on dopamine transmission can provide clues on the mechanism of the therapeutic effect of amphetamine and methylphenidate in ADHD. [15303307] Neural Plast 11(1-2): 77-95 (2004)
2009 21	Essential fatty acids and attention-deficit-hyperactivity disorder: a systematic review. [19549202] Dev Med Child Neurol 51(8): 580-92 (2009)
2007 22	Guanfacine and guanfacine extended release: treatment for ADHD and related disorders. [18078429] CNS Drug Rev 13(4): 465-74 (2007)
2008 23	Unrecognized attention-deficit/hyperactivity disorder in adults presenting with other psychiatric disorders. [19037178] CNS Spectr 13(11): 977-84 (2008)
2010 24	Lisdexamfetamine dimesylate: a prodrug stimulant for the treatment of ADHD in children and adults. [20448522] CNS Spectr 15(5): 315-25 (2010)
2009 25	Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study. [19883527] Health Technol Assess 13(50): iii-iv, ix-xi, 1-120 (2009)
2004 26	New options in the pharmacological management of attention-deficit/hyperactivity disorder. [15352538] Am J Manag Care 10(4 Suppl): S117-24 (2004)
2004 27	Attention-deficit/hyperactivity disorder: medication treatment-dosing and duration of action. [15352536] Am J Manag Care 10(4 Suppl): S99-106 (2004)
2004 28	Innovations in attention-deficit/hyperactivity disorder pharmacotherapy: long-acting stimulant and nonstimulant treatments. [15352535] Am J Manag Care 10(4 Suppl): S89-98 (2004)
2004 29	New approaches to the management and treatment of attention-deficit/hyperactivity disorder. [15352534] Am J Manag Care 10(4 Suppl): S87-8 (2004)
2006 30	Should children with ADHD and normal intelligence be routinely screened for underlying cytogenetic abnormalities? [16990360] Arch Dis Child 91(10): 860-1 (2006)
1994 31	Genetic and neurobiological aspects of attention deficit hyperactive disorder: a review. [8031743] J Psychiatry Neurosci 19(3): 193-201 (1994)
2008 32	Etiologic classification of attention-deficit/hyperactivity disorder. [18245408] Pediatrics 121(2): e358-65 (2008)
2005 33	Attention-deficit/hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications. [15930238] Pediatrics 115(6): 1734-46 (2005)
2005 34	Treatment of attention-deficit/hyperactivity disorder: overview of the evidence. [15930203] Pediatrics 115(6): e749-57 (2005)
2001 35	Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. [11581465] Pediatrics 108(4): 1033-44 (2001)
2001 36	Attention deficit hyperactivity disorder. [11527851] West J Med 175(3): 189-93 (2001)
1979 37	The clinical physiology of water metabolism. Part I: The physiologic regulation of arginine vasopressin secretion and thirst. [394480] West J Med 131(5): 373-400 (1979)
2003 38	Assessment and management of attention-deficit hyperactivity disorder in adults. [12642429] CMAJ 168(6): 715-22 (2003)
2001 39	How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. [11762571] CMAJ 165(11): 1475-88 (2001)
2010 40	Biomarker-guided interventions of clinically relevant conditions associated with autism spectrum disorders and attention deficit hyperactivity disorder. [20359266] Altern Med Rev 15(1): 15-32 (2010)
2007 41	EEG biofeedback in the treatment of attention deficit hyperactivity disorder. [17604459] Altern Med Rev 12(2): 146-51 (2007)
2008 42	Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder [corrected]: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing. [18427125] Circulation 117(18): 2407-23 (2008)
2008 43	Neuronal mechanisms underlying attention deficit hyperactivity disorder: the influence of arousal on prefrontal cortical function. [18591484] Ann N Y Acad Sci 1129(-): 236-45 (2008)
2008 44	ADHD in children and adolescents. [19445793] Clin Evid (Online) 2008(-): - (2008)
2004 45	Attention deficit hyperactivity disorder in adulthood. [15026486] J Neurol Neurosurg Psychiatry 75(4): 523-5 (2004)
2008 46	Recent developments in the psychosocial treatment of adult ADHD. [18928346] Expert Rev Neurother 8(10): 1537-48 (2008)
2011 47	Advances in understanding and treating ADHD. [21658285] BMC Med 9(-): 72 (2011)
2010 48	Distinguishing between attention-deficit hyperactivity and fetal alcohol spectrum disorders in children: clinical guidelines. [20856914] Neuropsychiatr Dis Treat 6(-): 509-15 (2010)
2011 49	Treatment of attention deficit hyperactivity disorder with monoamine amino acid precursors and organic cation transporter assay interpretation. [21326653] Neuropsychiatr Dis Treat 7(-): 31-8 (2011)
2010 50	New and extended-action treatments in the management of ADHD: a critical appraisal of lisdexamfetamine in adults and children. [20520740] Neuropsychiatr Dis Treat 6(-): 273-9 (2010)
2010 51	Attention-deficit/hyperactivity disorder and attention networks. [19759528] Neuropsychopharmacology 35(1): 278-300 (2010)
2009 52	Poor response inhibition: at the nexus between substance abuse and attention deficit/hyperactivity disorder. [18789354] Neurosci Biobehav Rev 33(5): 690-8 (2009)
2005 53	Are we ready for endophenotypes in attention deficit hyperactivity disorder? [16358104] Rev Bras Psiquiatr 27(4): 262-3 (2005)
2008 54	Understanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular function. [18295156] Child Adolesc Psychiatr Clin N Am 17(2): 459-74, xi (2008)
2010 55	The quality of life of children with attention deficit/hyperactivity disorder: a systematic review. [19633992] Eur Child Adolesc Psychiatry 19(2): 83-105 (2010)
2010 56	Molecular genetics of attention-deficit/hyperactivity disorder: an overview. [20145962] Eur Child Adolesc Psychiatry 19(3): 237-57 (2010)
2011 57	Preferences related to attention-deficit/hyperactivity disorder and its treatment. [21311700] Patient Prefer Adherence 5(-): 33-43 (2011)
2008 58	Psychopharmacological and other treatments in preschool children with attention-deficit/hyperactivity disorder: current evidence and practice. [18844482] J Child Adolesc Psychopharmacol 18(5): 413-47 (2008)
2010 59	Molecular genetics of attention deficit hyperactivity disorder. [20159345] Psychiatr Clin North Am 33(1): 159-80 (2010)
2009 60	The spontaneously hypertensive rat model of ADHD--the importance of selecting the appropriate reference strain. [19698722] Neuropharmacology 57(7-8): 619-26 (2009)
2007 61	The complexity of ADHD: diagnosis and treatment of the adult patient with comorbidities. [17667893] CNS Spectr 12(8 Suppl 12): 1-14; quiz 15-6 (2007)
2007 62	Lisdexamfetamine dimesylate: the first prodrug stimulant. [20532026] Psychiatry (Edgmont) 4(8): 39-45 (2007)
2011 63	Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis. [22074258] BMC Psychiatry 11(-): 176 (2011)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\ADHD.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\ADHD.php on line 92